In this way, our ambition becomes a reality by launching two key products in digestive pathology, aimed at alleviating two ailments that have a very negative impact on quality of life.
In our desire to find the best solution, DISIBEX was born as a treatment for dyspepsia (a very frequent pathology which was only partially addressed and improved by the drugs on the market).
At the same time, we address another symptom that produces enormous deterioration in the quality of life, which is Irritable Bowel Syndrome (estimated to be suffered by around 11% of the general population). Many of these patients do not seek medical assistance, causing a chronification of the dysfunction and great discomfort for those who suffer from it. SIIK was born from this dilemma, becoming a standard of treatment for our patients and healthcare professionals, with whom we work hand in hand to offer the best possible solutions.